Disseminated infection due to Mycobacterium bovis after intravesical BCG instillation

被引：0

作者：

Sara Marquez-Batalla ^{[1
]}

Esther Fraile-Villarejo ^{[1
]}

Moncef Belhassen-García ^{[2
]}

Nieves Gutierrez-Zubiaurre ^{[3
]}

Miguel Cordero-Sánchez ^{[2
]}

机构：

[1] Servicio de Medicina Interna (CAUSA),IBSAL,Universidad de Salamanca,37007 Salamanca,Spain

[2] Servicio de Medicina Interna,Seccion de Enfermedades Infecciosas,Complejo Asistencial Universitario de Salamanca (CAUSA),Instituto de investigacion Biomedica de Salamanca (IBSAL),Universidad de Salamanca,37007 Salamanca,Spain

来源：

World Journal of Clinical Cases | 2014年 / 07期

关键词：

Tuberculosis; Mycobacterium bovis; Bladder cancer; Bacillus Calmette-Guerin;

D O I：

暂无

中图分类号：

R527.3 [膀胱结核];

学科分类号：

1002 ; 100201 ;

摘要：

Intravesical bacillus Calmette-Guerin(BCG) instillation has been adopted for the treatment of patients with superficial bladder cancer. Severe adverse events due to local instillation of BCG are uncommon, with an overall rate of serious complications of less than 5%. We report the case of an immunocompetent adult patient with multi-system effects, namely pneumonitis, granulomatous hepatitis and meningitis, who responded well to standard treatment for Mycobacterium bovis. This case highlights the importance of a thorough assessment of this type of patient.

引用

页码：301 / 303

页数：3

共 8 条

[1] [Acute reactive arthritis after intravesical instillation of bacillus Calmette-Guérin. Two case reports and literature review]. Miranda S,Verdet M,Vernet M,Héron F,Vittecoq O,Levesque H,Marie I. La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne . 2010
[2] Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer. Lamm D L. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America . 2000
[3] Miliary Mycobacterium bovis induced by intravesical bacille Calmette-Guérin immunotherapy. McParland C,Cotton D J,Gowda K S,Hoeppner V H,Martin W T,Weckworth P F. The American review of respiratory disease . 1992
[4] Four cases of disseminated Mycobacterium bovis infection following intravesical BCG instillation for treatment of bladder carcinoma
Nadasy, Krisztina A.
Patel, Rikin S.
Emmett, Michael
Murillo, Ricardo A.
Tribble, Marc A.
Black, Robert D.
Sutker, William L.
[J]. SOUTHERN MEDICAL JOURNAL, 2008, 101 (01) : 91 - 95
[5] An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer[J] . &nbspEuropean Urology . 2009 (2)
[6] Disseminated Mycobacterium bovis after intravesicular bacillus calmette-Gu rin treatments for bladder cancer. Elkabani M,Greene J N,Vincent A L,VanHook S,Sandin R L. Cancer control : journal of the Moffitt Cancer Center . 2000
[7] Short-term administration of prulifloxacin in patients with nonmuscle-invasive bladder cancer : an effective option for the prevention of bacillus Calmette-Guérin-induced toxicity?. Rocco Damiano,Marco De Sio,Giuseppe Quarto,Giuseppe Di Lorenzo,Sisto Perdonà,Italo M. Palumbo,Giuseppina Azzarito,Francesco Giugliano,Riccardo Autorino. BJU International . 2009
[8] Spectrum of Bacille Calmette-Guérin (BCG) Infection after Intravesical BCG Immunotherapy. Y. Gonzalez Omar,M. Musher Daniel,Brar Indira,Furgeson Seth,R. Boktour Maha,J. Septimus Edward,J. Hamill Richard,A. Graviss Edward. Clinical Infectious Diseases . 2003

← 1 →